加多克西酸增强的MRI评分模型用于预测肝细胞癌的病理特征

Kun Zhang¹, Kan He¹, Lei Zhang¹+10

• ¹From the Department of Radiology, Medical Imaging Institute of Tianjin, Tianjin First Central Hospital, School of Medicine, Nankai University, 24 Fukang Rd, Nankai District, Tianjin 300192, China (K.Z., S.S.X., L.Y.L., S.X., W.S.); Department of Radiology, First Hospital of Jilin University, Changchun, China (K.H., L.Z., Y.Z.C., H.M.Z.); Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China (W.C.L., Z.X.Y.); Tianjin Key Laboratory of Digestive Cancer, Tianjin, China (W.C.L., Z.X.Y.); State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin, China (W.C.L., Z.X.Y.); Tianjin's Clinical Research Center for Cancer, Tianjin, China (W.C.L., Z.X.Y.); Philips Healthcare, Beijing, China (Z.W.S.); and Department of Immunology, Nankai University School of Medicine, Nankai University, Tianjin, China (X.M.S.).